GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Essilorluxottica (OTCPK:ESLOY) » Definitions » EBIT

Essilorluxottica (Essilorluxottica) EBIT : $3,513 Mil (TTM As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Essilorluxottica EBIT?

Essilorluxottica's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was $1,542 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $3,513 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Essilorluxottica's annualized ROC % for the quarter that ended in Dec. 2023 was 3.73%. Essilorluxottica's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 34.22%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Essilorluxottica's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 3.23%.


Essilorluxottica EBIT Historical Data

The historical data trend for Essilorluxottica's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Essilorluxottica EBIT Chart

Essilorluxottica Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,894.44 552.31 2,623.73 3,377.12 3,525.63

Essilorluxottica Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,186.44 1,824.52 1,548.73 1,970.75 1,541.99

Competitive Comparison of Essilorluxottica's EBIT

For the Medical Instruments & Supplies subindustry, Essilorluxottica's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Essilorluxottica's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Essilorluxottica's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Essilorluxottica's EV-to-EBIT falls into.



Essilorluxottica EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $3,513 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Essilorluxottica  (OTCPK:ESLOY) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Essilorluxottica's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=2970.556 * ( 1 - 22.49% )/( (62746.478 + 60764.451)/ 2 )
=2302.4779556/61755.4645
=3.73 %

where

Invested Capital(Q: Jun. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=65249.187 - 3399.783 - ( 1828.819 - max(0, 10717.226 - 9820.152+1828.819))
=62746.478

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=66001.091 - 5258.451 - ( 2790.622 - max(0, 10622.683 - 10600.872+2790.622))
=60764.451

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Essilorluxottica's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=3083.97/( ( (8538.462 + max(359.697, 0)) + (8997.819 + max(130.86, 0)) )/ 2 )
=3083.97/( ( 8898.159 + 9128.679 )/ 2 )
=3083.97/9013.419
=34.22 %

where Working Capital is:

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3264.355 + 3159.263 + 1567.715) - (3399.783 + 0 + 4231.853)
=359.697

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3201.745 + 2998.909 + 1609.596) - (5258.451 + 0 + 2420.939)
=130.86

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Essilorluxottica's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=3512.733/108643.238
=3.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Essilorluxottica EBIT Related Terms

Thank you for viewing the detailed overview of Essilorluxottica's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Essilorluxottica (Essilorluxottica) Business Description

Address
147, Rue de Paris, Charenton-Le-Pont, Paris, FRA, 94220
EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufacturer of optical lenses. Both companies are significantly larger than the next biggest player in their respective fields and command over 15% of the fragmented global eyewear market. The company has a broad geographical presence, with around 36% of sales in Europe, 47% in North America, and the rest in Asia and Latin America.

Essilorluxottica (Essilorluxottica) Headlines

From GuruFocus

Dan Loeb Buys David Herro Stock EssilorLuxottica

By Holly LaFon Holly LaFon 08-26-2019

Daniel Loeb Comments on EssilorLuxottica

By Sydnee Gatewood Sydnee Gatewood 04-22-2020

Daniel Loeb Comments on EssilorLuxottica

By Sydnee Gatewood Sydnee Gatewood 10-24-2019

Chris Davis Comments on Essilor International SA

By Vera Yuan Vera Yuan 09-09-2014

TOCQUEVILLE ASSET MANAGEMENT L.P. Cuts Portfolio Down to Size in 1st Quarter

By GuruFocus Research GuruFocus Editor 05-19-2022